Matinas BioPharma (MTNB) Announces Issuance of US Patent for Prescription-Only Next Generation Omega-3 MAT9001
Matinas BioPharma (MTNB) Announces Issuance of US Patent for Prescription-Only Next Generation Omega-3 MAT9001 StreetInsider.com Matinas BioPharma Announces Issuance of Key US Patent for Prescription-Only Next Generation Omega-3 MAT9001 … GlobeNewswire (press release) Matinas BioPharma shares pop on patent approval for MAT9001 Proactive Investors USA & Canada Full coverage